SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group (OTCBB:BMSN) Chairman and CEO David R. Koos gives his views about rolling out a new direction in stem cell banking by providing the first commercial adult stem cell processing and banking facility in the U.S. that is focused on harvesting non-controversial stem cells from adipose, or fat tissue, and the biotechnology company’s plans for penetrating the market with its disposable instruments for use in stem cell harvesting and tissue transfer initially targeting plastic surgeons and their liposuction patients in a Q & A interview published May 14, 2007 in The Wall Street Transcript (twst.com).
